4.8 Article

Control of vesicle fusion by a tyrosine phosphatase

期刊

NATURE CELL BIOLOGY
卷 6, 期 9, 页码 831-U3

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1164

关键词

-

资金

  1. Canadian Institutes of Health Research [13465] Funding Source: Medline
  2. NCI NIH HHS [CA96949] Funding Source: Medline
  3. NIAID NIH HHS [AI48032, AI55741, AI35603, AI53585] Funding Source: Medline
  4. NIA NIH HHS [AG00252] Funding Source: Medline

向作者/读者索取更多资源

The tyrosine phosphatase PTP-MEG2 is targeted by its amino-terminal Sec14p homology domain to the membrane of secretory vesicles. There it regulates vesicle size by promoting homotypic vesicle fusion by a mechanism that requires its catalytic activity. Here, we identify N-ethylmaleimide-sensitive factor (NSF), a key regulator of vesicle fusion, as a substrate for PTP-MEG2. PTP-MEG2 reduced the phosphotyrosine content of NSF and co-localized with NSF and syntaxin 6 in intact cells. Furthermore, endogenous PTP-MEG2 co-immunoprecipitated with endogenous NSF. Phosphorylation of NSF at Tyr 83, as well as an acidic substitution at the same site, increased its ATPase activity and prevented alphaSNAP binding. Conversely, expression of a Y83F mutant of NSF caused spontaneous fusion events. Our results suggest that the molecular mechanism by which PTP-MEG2 promotes secretory vesicle fusion involves the local release of NSF from a tyrosine-phosphorylated, inactive state. This represents a novel mechanism for localized regulation of NSF and the first demonstrated role for a protein tyrosine phosphatase in the regulated secretory pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据